Postconditioning: "Toll-erating" mesenteric ischemia-reperfusion injury?

Olivér Rosero1, Péter Ónody1, Tibor Kovács1

  • 11st Department of Surgery, Semmelweis University, Budapest, Hungary.

Surgery
|November 16, 2016
PubMed
Abstract

Insights

Postconditioning effectively reduced intestinal ischemia-reperfusion injury by decreasing toll-like-receptor-4 expression and improving the inflammatory response. This method offers a promising strategy for mitigating organ damage after mesenteric arterial occlusion.

Area of Science:

  • Gastroenterology
  • Surgical Research
  • Immunology

Background:

  • Ischemia-reperfusion injury (IRI) of the intestine is a significant clinical concern following mesenteric artery occlusion.
  • Toll-like receptor 4 (TLR4) plays a critical role in the inflammatory cascade and organ damage associated with IRI.

Purpose of the Study:

  • To investigate the therapeutic potential of postconditioning in reducing intestinal IRI.
  • To examine the effect of postconditioning on the mucosal expression of toll-like receptor 4 (TLR4) in a rat model.

Main Methods:

  • Male Wistar rats underwent superior mesenteric artery occlusion for 60 minutes followed by 6 hours of reperfusion.
  • Postconditioning was applied using alternating cycles of reperfusion and reocclusion.
  • Assessment included intestinal histopathology, immunohistochemistry for caspase-3, antioxidant status, and protein levels of HMGB1 and TLR4, as well as inflammatory cytokines (IL-6, TNF-α).

Main Results:

  • Postconditioning significantly ameliorated histologic damage in the intestine compared to the IRI group.
  • Reduced expression of caspase-3, TLR4 mRNA, HMGB1, IL-6, and TNF-α was observed in postconditioned rats.
  • An improved antioxidant status of the intestinal mucosa was noted in the postconditioned group.

Conclusions:

  • Postconditioning is an effective strategy for mitigating small intestinal ischemia-reperfusion injury in rats.
  • The protective effects of postconditioning may be mediated by the downregulation of toll-like receptor 4 (TLR4) expression and a more favorable inflammatory profile.

Related Concept Videos